Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Single-Chain Variable Fragment Fusion Proteins for Targeted Delivery and Therapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 29, 2026
Targeting the IRE1α-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcoma.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
CRISPR Interference to Inhibit Oncogenes for Cancer Therapy.
Journal: International journal of molecular sciences
Published: March 30, 2026
Aptamer-Based Delivery of Genes and Drugs Across the Blood-Brain Barrier.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 29, 2025
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma.
Journal: Oncogene
Published: November 12, 2025
Exome sequencing and analysis of 44,028 British South Asians enriched for high autozygosity.
Journal: Nature genetics
Published: June 08, 2025
Regulation of Cancer Metastasis by PAK2.
Journal: International journal of molecular sciences
Published: November 22, 2024
Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 20, 2024
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology.
Journal: Bioactive materials
Published: June 29, 2024
Extreme Phenotype Sampling and Next Generation Sequencing to Identify Genetic Variants Associated with Tacrolimus in African American Kidney Transplant Recipients.
Journal: Research square
Published: April 01, 2024
Last Updated: 09/26/2026